MedPAC Considering Two Options For Reinstating Medicare Least Costly Alternative Policy For Drugs
This article was originally published in The Pink Sheet Daily
Executive SummaryBoth proposals involve legislation that would authorize Medicare Part B to pay for drugs based on the price of the lowest-cost alternative.
You may also be interested in...
Comments by members of the Medicare Payment Advisory Commission at a recent meeting suggest an opportunity for pharmaceutical industry stakeholders to help frame the discussion of Medicare value-based payment approaches for Part B drugs.